Dr. Ulrickson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2940 E Banner Gateway Dr
Ste 450
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-3359
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2010 - 2013
- Massachusetts General HospitalResidency, Internal Medicine, 2007 - 2010
- McGovern Medical School at UTHealthClass of 2007
Certifications & Licensure
- AZ State Medical License 2013 - 2027
- CO State Medical License 2021 - 2023
- WA State Medical License 2010 - 2014
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Three-year follow-up analysis of first-line axicabtagene ciloleucel in high-risk large B-cell lymphoma (ZUMA-12).Julio C Chavez, Michael Dickinson, Javier Munoz, Matthew L Ulrickson, Catherine Thieblemont
Blood. 2025-02-12 - Enasidenib in relapsed aggressive systemic mastocytosis with IDH2 mutation.Alejandro Del Rio Verduzco, Ali Al Darobi, Alex Heimbigner, Hayley Heers, Matthew Ulrickson
Leukemia & Lymphoma. 2025-01-01 - 3 citationsFive-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, John Tamaresis, Armin Ghobadi
Journal of Clinical Oncology. 2024-10-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: